Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ILMN Illumina

未开盘 04-25 16:00:00 EDT

121.05

-1.82

-1.48%

盘后120.67

-0.38-0.31%

19:49 EDT

最高122.04	最低116.91	成交量96.25万
今开121.97	昨收122.87	日振幅4.17%
总市值192.78亿	流通市值192.18亿	总股本1.59亿
成交额1.15亿	换手率0.61%	流通股本1.59亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ILMN","market":"US","secType":"STK","nameCN":"Illumina","latestPrice":121.05,"timestamp":1714075200000,"preClose":122.87,"halted":0,"volume":962511,"hourTrading":{"tag":"盘后","latestPrice":120.67,"preClose":121.05,"latestTime":"19:49 EDT","volume":13498,"amount":1633404.36,"timestamp":1714088966783},"delay":0,"floatShares":158760419,"shares":159255385,"eps":-7.348101,"marketStatus":"未开盘","marketStatusCode":0,"change":-1.82,"latestTime":"04-25 16:00:00 EDT","open":121.97,"high":122.035,"low":116.91,"amount":115168714.69883999,"amplitude":0.041711,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.348101,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714118400000},"adr":0,"listingDate":964756800000,"adjPreClose":122.87,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":121.78,"preClose":122.87,"latestTime":"09:29 EDT","volume":2962,"amount":361404.10548,"timestamp":1714051799999},"postHourTrading":{"tag":"盘后","latestPrice":120.67,"preClose":121.05,"latestTime":"19:49 EDT","volume":13498,"amount":1633404.36,"timestamp":1714088966783},"volumeRatio":0.69371,"optionData":{"bulkOrders":[{"symbol":"ILMN","call":false,"expireDate":1718942400000,"strike":"90.0","timestamp":1714055164905,"price":1.309999942779541,"volume":4234,"amount":554654,"type":"-"}]}},"requestUrl":"/m/hq/s/ILMN","defaultTab":"news","newsList":[{"id":"2426099052","title":"欧盟批准 Illumina 剥离癌症测试制造商 Grail 的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2426099052","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426099052?lang=zh_cn&edition=full","pubTime":"2024-04-12 17:45","pubTimestamp":1712915104,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社布鲁塞尔4月12日 - 欧盟执行委员会周五发表声明说，批准了Illumina公司  解除对癌症诊断测试制造商Grail  的收购计划。 美国基因测序公司Illumina在与美国和欧洲的反垄断执法机构进行了两年多的斗争，并遭到激进投资者卡尔-伊坎（Carl Icahn）的激烈反对之后，于去年年底宣布 (link)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426241061","title":"更新版 2-更正-Illumina 首席财务官 Goswami 将离职，Summit Therapeutics 前高管 Dhingra 接替其职位","url":"https://stock-news.laohu8.com/highlight/detail?id=2426241061","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426241061?lang=zh_cn&edition=full","pubTime":"2024-04-10 05:28","pubTimestamp":1712698104,"startTime":"0","endTime":"0","summary":"     路透社4月9日 - Illumina   周二表示，首席财务官Joydeep Goswami将离开这家基因测序公司，由Summit Therapeutics   前高管安库尔-丁格拉接任。他还在设备制造商安捷伦科技公司工作了约18年。Illumina还重申了对2024年第一季度和全年的预测。Illumina公司曾在12月表示，它将剥离  癌症诊断测试制造商Grail  ，此前两家公司与美国和欧洲的反垄断执法机构进行了两年多的斗争，并遭到了激进投资者卡尔-伊坎的激烈反对。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426125353","title":"Illumina 首席财务官 Goswami 将离职，Summit Therapeutics 的 Dhingra 被任命为继任者","url":"https://stock-news.laohu8.com/highlight/detail?id=2426125353","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426125353?lang=zh_cn&edition=full","pubTime":"2024-04-10 04:18","pubTimestamp":1712693928,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月9日 - Illumina公司  周二表示，首席财务官Joydeep Goswami将离开这家基因测序公司，由Summit Therapeutics公司  高管Ankur Dhingra接任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119080","title":"加拿大皇家银行：重申Illumina(ILMN.US)评级，由优于大市调整至优于大市评级, 目标价253.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119080","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426119080?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:46","pubTimestamp":1712670368,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：重申Illumina(ILMN.US)评级，由优于大市调整至优于大市评级, 目标价253.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092146098b03a877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092146098b03a877&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421043994","title":"Illumina, Inc.盘中异动 早盘大幅拉升6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421043994","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421043994?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:32","pubTimestamp":1711027921,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时32分，Illumina, Inc.股票出现异动，股价急速上涨6.11%。Illumina, Inc.股票所在的生命科学行业中，整体涨幅为0.34%。Illumina, Inc.公司简介：Illumina 为生命科学和临床实验室应用提供分析遗传物质的工具和服务。Illumina的高通量技术使人类和其他大型生物的全基因组测序成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212132028b511dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212132028b511dd3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419707563","title":"独家-消息人士称伊坎放弃挑战 Illumina 董事会的威胁","url":"https://stock-news.laohu8.com/highlight/detail?id=2419707563","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419707563?lang=zh_cn&edition=full","pubTime":"2024-03-13 01:36","pubTimestamp":1710265016,"startTime":"0","endTime":"0","summary":"伊坎和 Illumina 拒绝发表评论。消息人士称，伊坎已经为针对Illumina的第二次代理权争夺战准备了几个月，他与潜在的董事会董事取得了联系，并就Illumina股东是否会支持他征求了专家的意见。伊坎去年获得了足够多的 Illumina 股东支持，使他提名的三位候选人中的一位当选为董事会董事。Illumina创建了Grail公司，并于2016年将其剥离。Illumina持有12%的股份，并于2021年决定收购Grail，进军癌症早期检测市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414835341","title":"Illumina Inc盘中异动 大幅上涨5.01%报139.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414835341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414835341?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:00","pubTimestamp":1708959600,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时00分，Illumina Inc股票出现异动，股价急速上涨5.01%。Illumina Inc股票所在的生命科学行业中，整体跌幅为0.08%。Illumina的高通量技术使人类和其他大型生物的全基因组测序成为可能。消息层面，截至23时00分，《Illumina董事增持7,330股普通股股份，价值约99.17万美元》资讯为影响Illumina Inc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226230000861d8692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240226230000861d8692&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414028759","title":"郑磊履新因美纳全球高级副总裁兼大中华区总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2414028759","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2414028759?lang=zh_cn&edition=full","pubTime":"2024-02-26 10:57","pubTimestamp":1708916220,"startTime":"0","endTime":"0","summary":"上海2024年2月26日 /美通社/ -- 全球基因测序和芯片技术的领导者因美纳，今日宣布郑磊女士将担任因美纳全球高级副总裁兼大中华区总经理，并成为全球执行管理团队的一员，该任命即日生效。郑磊女士在全球医疗健康、制药领域拥有逾25年的丰富经验。因美纳欧洲负责人兼代理全球首席商务官Bas Verhoef表示：\"我们很高兴郑磊女士加入因美纳，她在医疗健康领域的深厚积累与全球商业经验将为公司大中华区业务发展以及全球商业团队增添助力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4344982_ZH44982_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411556631","title":"Illumina已面临来自伊坎的压力，年底又迎来了其他激进分子","url":"https://stock-news.laohu8.com/highlight/detail?id=2411556631","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411556631?lang=zh_cn&edition=full","pubTime":"2024-02-15 07:53","pubTimestamp":1707954793,"startTime":"0","endTime":"0","summary":"在买入之前，Illumina 的股价在今年大部分时间都在走低，即使投资者支持伊坎关于公司需要变革的观点，并选举了他的一位董事候选人进入 Illumina 董事会。ValueAct 在 2023 年第三季度建立了 Illumina 的仓位，并在第四季度减持了 37% 的股份。在Illumina表示将剥离Grail的第二天，伊坎致信Illumina其他股东，称他计划赶走董事，为第二次挑战董事会打下基础。他提交的文件显示，截至 12 月底，伊坎持有 43 万股 Illumina 股票，与上一季度持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411680983","title":"Illumina Inc盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411680983","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411680983?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:43","pubTimestamp":1707835426,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时43分，Illumina Inc股票出现异动，股价快速下跌5.14%。Illumina Inc股票所在的生命科学行业中，整体跌幅为1.31%。Illumina Inc公司简介：Illumina 为生命科学和临床实验室应用提供分析遗传物质的工具和服务。Illumina的高通量技术使人类和其他大型生物的全基因组测序成为可能。Illumina还销售微阵列，使低成本、集中的基因筛查，主要应用于消费和农业领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132243477a437808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132243477a437808&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410906364","title":"Illumina Inc盘中异动 临近午盘快速下跌5.00%报136.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410906364","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410906364?lang=zh_cn&edition=full","pubTime":"2024-02-10 00:53","pubTimestamp":1707497622,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日00时53分，Illumina Inc股票出现异动，股价快速下跌5.00%。截至发稿，该股报136.16美元/股，成交量177.129万股，换手率1.12%，振幅8.03%。Illumina Inc股票所在的生命科学行业中，整体跌幅为0.70%。Illumina Inc公司简介：Illumina 为生命科学和临床实验室应用提供分析遗传物质的工具和服务。Illumina的高通量技术使人类和其他大型生物的全基因组测序成为可能。Illumina还销售微阵列，使低成本、集中的基因筛查，主要应用于消费和农业领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100053427a42d834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100053427a42d834&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410782887","title":"受需求低迷拖累，Illumina 预计 2024 年销售额持平","url":"https://stock-news.laohu8.com/highlight/detail?id=2410782887","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410782887?lang=zh_cn&edition=full","pubTime":"2024-02-09 06:22","pubTimestamp":1707430966,"startTime":"0","endTime":"0","summary":"    路透2月8日 - Illumina  周四预测，由于基因检测工具和诊断产品的需求低迷将延续到今年，其年度核心业务收入将与2023财年几乎持平。该公司本季度共交付了 79 台该仪器，2023 年全年共交付 352 台。这家基因测序公司表示，由于Grail剥离的具体时间和影响仍不确定，公司正将财务前景重点放在核心业务Illumina上。总部位于加利福尼亚州圣迭戈的 Illumina 公司股价在延时交易中下跌 2.7%，至 139.5 美元。剥离条款预计将于 2024 年第二季度敲定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409377392","title":"Illumina Inc   预计每股收益2美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409377392","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409377392?lang=zh_cn&edition=full","pubTime":"2024-02-07 06:32","pubTimestamp":1707258761,"startTime":"0","endTime":"0","summary":"   * Illumina公司   将于2月8日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，17位分析师的平均预期显示，这家总部位于加利福尼亚州圣迭戈的公司的营收预计将从去年同期的10.8亿美元增至10.88亿美元，增幅为0.5%。   * LSEG 分析师对 Illumina 公司的平均预期为每股收益 2 美分。* 华尔街对 Illumina Inc 的 12 个月目标价中位数为 144.00 美元，高于其上次收盘价 142.23 美元。2月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403880684","title":"美国研究综述-中心空间、荷兰兄弟、签证","url":"https://stock-news.laohu8.com/highlight/detail?id=2403880684","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403880684?lang=zh_cn&edition=full","pubTime":"2024-01-16 15:12","pubTimestamp":1705389140,"startTime":"0","endTime":"0","summary":"* 荷兰兄弟公司  ：Stifel将其评级从 \"持有 \"上调至 \"买入\"。* Visa Inc   ：杰富瑞将目标价从 300 美元上调至 305 美元             * 富国银行  ：杰富瑞将目标价从 54 美元下调至 52 美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402158500","title":"BUZZ-Illumina 接近完成头肩底形态","url":"https://stock-news.laohu8.com/highlight/detail?id=2402158500","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402158500?lang=zh_cn&edition=full","pubTime":"2024-01-10 00:26","pubTimestamp":1704817567,"startTime":"0","endTime":"0","summary":"    1月9日 - ** 1 月 4 日，我们的 Illumina 技术文章  指出头肩底正在形成** 今天，Illumina 公司  因第四季度初步营收超出预期而上涨  ** 开盘时股价跳空上涨，涨破 10-DMA 线，创下 4 个月新高 147.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402371941","title":"BUZZ--美国股票走势-Albemarle、Illumina、Eversource Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2402371941","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402371941?lang=zh_cn&edition=full","pubTime":"2024-01-09 23:52","pubTimestamp":1704815550,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月9日 - 华尔街主要股指周二下跌，大型股因国债收益率上升而承压，交易商在本周晚些时候发布关键通胀报告之前缩减了提前开始降息的预期。美东时间10:33，道琼斯工业平均指数  下跌0.68%，报37427.22点。标普500指数  下跌0.46%，报4741.82点；纳斯达克综合指数  下跌0.52%，报14766.438点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402139269","title":"Illumina Inc盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402139269","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402139269?lang=zh_cn&edition=full","pubTime":"2024-01-09 22:39","pubTimestamp":1704811153,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日22时39分，Illumina Inc股票出现波动，股价急速上涨5.01%。Illumina Inc股票所在的生命科学行业中，整体涨幅为0.80%。其相关个股中，Illumina Inc、Bioaffinity Technologies Inc、Revvity Inc涨幅较大，纽勤、T2 Biosystems Inc、Mdxhealth较为活跃，换手率分别为0.31%、0.27%、0.20%，振幅较大的相关个股有纽勤、Neuronetics Inc、Personalis Inc，振幅分别为7.96%、7.86%、5.01%。Illumina Inc公司简介：Illumina 为生命科学和临床实验室应用提供分析遗传物质的工具和服务。Illumina的高通量技术使人类和其他大型生物的全基因组测序成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092239137907698a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401092239137907698a&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.illumina.com","stockEarnings":[{"period":"1week","weight":0.0374},{"period":"1month","weight":-0.0953},{"period":"3month","weight":-0.1392},{"period":"6month","weight":0.1083},{"period":"1year","weight":-0.4262},{"period":"ytd","weight":-0.1306}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Illumina, Inc.是一家生命科学用具以及用于分析基因变异和基因功能的整合系统的一流开发商、制造商和销售商。公司于1998年4月在加利福尼亚州组成，2000年7月在特拉华州完成重组。公司利用专利技术提供一系列的基因分析方案以及为高度相联的市场提供产品和服务，包括基因序列、基因类型、基因表达和分子诊断市场。该公司的客户包括领先的基因组研究中心、学术机构、政府管辖的实验室、临床研究组织以及制药公司、生物科技公司、农产品基因组鉴定研发公司和客户基因组鉴定公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.708333,"avgChangeRate":0.095946},{"month":2,"riseRate":0.375,"avgChangeRate":-0.031971},{"month":3,"riseRate":0.583333,"avgChangeRate":0.006724},{"month":4,"riseRate":0.625,"avgChangeRate":0.018125},{"month":5,"riseRate":0.565217,"avgChangeRate":0.046293},{"month":6,"riseRate":0.695652,"avgChangeRate":0.033492},{"month":7,"riseRate":0.695652,"avgChangeRate":0.012346},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.007305},{"month":9,"riseRate":0.5,"avgChangeRate":0.000534},{"month":10,"riseRate":0.541667,"avgChangeRate":0.015004},{"month":11,"riseRate":0.541667,"avgChangeRate":0.009427},{"month":12,"riseRate":0.666667,"avgChangeRate":0.03466}],"exchange":"NASDAQ","name":"Illumina","nameEN":"Illumina"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Illumina,ILMN,Illumina股票,Illumina股票老虎,Illumina股票老虎国际,Illumina行情,Illumina股票行情,Illumina股价,Illumina股市,Illumina股票价格,Illumina股票交易,Illumina股票购买,Illumina股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Illumina(ILMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Illumina(ILMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}